Experienced in Hypertrichosis-Acromegaloid Facial Appearance Syndrome

Alexandra Willer-Kautzky

Vienna, AT 
Experienced in Hypertrichosis-Acromegaloid Facial Appearance Syndrome
Vienna, AT 
OverviewLocationsClinical Research

Overview

Alexandra Willer-Kautzky practices in Vienna, Austria. Ms. Willer-Kautzky is rated as an Experienced expert by MediFind in the treatment of Hypertrichosis-Acromegaloid Facial Appearance Syndrome. Her top areas of expertise are Gestational Diabetes, Type 2 Diabetes (T2D), Obesity, Gastric Bypass, and Hormone Replacement Therapy (HRT).

Her clinical research consists of co-authoring 407 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 4 articles in the study of Hypertrichosis-Acromegaloid Facial Appearance Syndrome.

Gender
Female

Locations

Vienna, 1090, Austria
Other Locations
Landesklinikum Scheibbs
Scheibbs, 3270, Austria
Gars Am Kamp, Austria

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: August 24, 2025
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
A Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Venglustat in Late-onset GM2 Gangliosidosis (Tay-Sachs Disease and Sandhoff Disease) Together With a Separate Basket for Juvenile/Adolescent Late-onset GM2 Gangliosidosis and Ultra-rare Diseases Within the Same and Similar Glucosylceramide-based Sphingolipid Pathway
A Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Venglustat in Late-onset GM2 Gangliosidosis (Tay-Sachs Disease and Sandhoff Disease) Together With a Separate Basket for Juvenile/Adolescent Late-onset GM2 Gangliosidosis and Ultra-rare Diseases Within the Same and Similar Glucosylceramide-based Sphingolipid Pathway
Enrollment Status: Terminated
Publish Date: December 30, 2024
Intervention Type: Drug
Study Drug: Venglustat GZ402671
Study Phase: Phase 3
View 1 Less Clinical Trial

407 Total Publications

Cluster-Based Immunization Patterns in Diabetes Mellitus: Insights for Personalized Preventive Care.
Cluster-Based Immunization Patterns in Diabetes Mellitus: Insights for Personalized Preventive Care.
Journal: Journal of personalized medicine
Published: July 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Willer-Kautzky's expertise for a condition
ConditionClose
View All 10 Advanced Conditions
View All 54 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile